Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 82 citing articles:

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 406
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Nature Medicine (2022) Vol. 29, Iss. 2, pp. 344-347
Open Access | Times Cited: 374
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
Sarah A. Buchan, Hannah Chung, Kevin A. Brown, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2232760-e2232760
Open Access | Times Cited: 277
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 262
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
Jing Zou, Hongjie Xia, Xuping Xie, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 116
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
Brock Kingstad-Bakke, Woojong Lee, S Chandrasekar, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 20
Open Access | Times Cited: 110
Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
Hongjie Xia, Jing Zou, Chaitanya Kurhade, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 4, pp. 485-488.e3
Open Access | Times Cited: 95
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant
Vineet Sharma, Himanshu Rai, Dev Nath Singh Gautam, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1876-1885
Open Access | Times Cited: 77
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain
Nathaniel L. Miller, Thomas A. Clark, Rahul Raman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100527-100527
Open Access | Times Cited: 67
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Yanping Hu, Jing Zou, Chaitanya Kurhade, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 44
Role of T cells in severe COVID-19 disease, protection, and long term immunity
Julia Maret Hermens, Can Keşmir
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 295-307
Open Access | Times Cited: 42
Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
Jianguo Zhang, Nan Chen, Daguo Zhao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 61
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
Hassen Kared, Asia‐Sophia Wolf, Amin Alirezaylavasani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
SARS‐CoV‐2 Omicron and its current known unknowns: A narrative review
Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Thi Hien Hau, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 41
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1828-1832
Open Access | Times Cited: 39
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose
Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 6, pp. 983-994
Open Access | Times Cited: 38
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
Wanbo Tai, Shengyong Feng, Benjie Chai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top